Sektor Galectin Therapeutics Inc.

Aktien

A1JV3R

US3632252025

GALT

Biotechnologie

Markt geschlossen - 21:00:00 29.10.2026 Perf. 5 T Veränd. 1. Jan.
3.520 USD -0.56% Intraday Chart für Galectin Therapeutics Inc. +4.45% -15.38%
Hauptkonkurrenten
% % 5 Tage Veränd. 1 Monat Veränd. 3 Monate % 1. Jan. Perf. 1 Jahr Perf. 3 Jahre Veränd. 5 Jahre Veränd. 10 Jahre Marktkap.($)
-0.56%+4.45%-10.43%+3.83%-15.38%-31.52%+76.88%+10.34%+369.33% 357 Mio.
+0.34%-3.03%-11.69%+16.15%+57.65%+37.45%+61.06%+6.44% - 64.14 Mrd.
+0.98%+2.26%-4.76%+4.20%+12.22%+12.91%+82.98%+234.33%+5’517.32% 55.53 Mrd.
+1.75%+2.76%+9.69%+14.39%+19.15%+12.38%+103.69%-15.55%+239.95% 53.03 Mrd.
-1.43%-0.57%+1.51%+13.22%+22.03%+26.10%+52.86%+6.95%+283.25% 45.99 Mrd.
-0.48%-3.86%+1.24%+12.44%+22.30%+17.27%+117.99%+1.91%+1’010.13% 42.45 Mrd.
+0.82%-2.06%-5.69%+3.49%+138.88%+227.09%+922.41%+539.56% - 40.45 Mrd.
-0.26%-4.20%+6.17%+6.71%+9.81%+10.86%+45.18%+6.84%+157.79% 32.25 Mrd.
-2.07%+44.58%+64.55%+98.53%+86.88%+102.84%+88.74%+33.43%+235.22% 34.47 Mrd.
-2.72%-8.79%-15.62%+16.80%+43.32%+22.58%-5.63%-60.89% - 24.23 Mrd.
+1.30%-2.37%-10.04%-3.59%-6.38%-15.14%-2.27%-68.61% - 22.1 Mrd.
+15.06%+18.66%-5.17%+7.16%-35.88%-32.49%+367.29%+277.12%+724.15% 21.18 Mrd.
-2.18%+2.28%+10.00%+18.67%+20.64%+16.71%+170.72%+208.39%+2’245.31% 19.38 Mrd.
+0.57%+9.06%+27.67%+56.43%+88.54%+100.13%+117.92%-14.29%+394.87% 17.85 Mrd.
+0.97%+7.64%+10.62%+27.09%+39.55%+42.75%+88.16%-15.37%+112.26% 16.69 Mrd.
-0.12%+2.51%+13.41%+17.15%+51.04%+65.19%+227.72%+204.23%+508.46% 16.42 Mrd.
+1.38%+5.90%+9.98%-0.57% - - - - - 16.39 Mrd.
+3.33%+5.53%+7.36%+11.21%+192.66%+175.10%+360.46%+1’478.53%+825.12% 15.33 Mrd.
+0.62%+16.32%+22.73%+19.55%+18.25%+21.24%-8.43%-24.77%+168.28% 16.04 Mrd.
+0.97%-7.48%-3.82%-13.90%+11.63%+3.79%+468.94% - - 13.21 Mrd.
Durchschnitt +0.91%+3.92%+5.89%+16.45%+40.89%+42.91%+175.61%+156.03%+913.67% 28.37 Mrd.
Nach Marktkapitalisierung gewichteter Durchschnitt +0.70%+3.36%+4.90%+17.27%+42.28%+45.86%+168.97%+126.83%+1’239.84%
  1. Börse
  2. Aktien
  3. A1JV3R Aktie
  4. Sektor Galectin Therapeutics Inc.